药械

MedSci主页 / 所有栏目 / 药械

全新的中国创新药研发管线收藏：

2020-07-09 Clindata Clindata

上海中山医院医生/ 主任医师

中国创新药研发管线大全，包括了恒瑞等公司，也包括百济，信达，君实等创新药企业

1恒瑞

2翰森制药

3中国生物制药中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

4复星医药

复宏汉霖

复创医药

复星医药

5石药集团

6科伦药业

7丽珠集团

8绿叶制药

9贝达药业

10康弘药业

11君实生物

12信达生物

13百济神州

14基石药业

15康宁杰瑞

16再鼎

17迈博药业

18微芯生物

19百奥泰

20泽璟制药

21亚盛医药

22天境生物

23开拓药业

24上海海和

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

25迪哲医药

26诺诚健华

27和记黄埔

28沈阳三生

29东阳光药

30海思科

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

31神州细胞

32德琪医药

33艾森医药

34艾力斯医药

35劲方药业

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

36迈博斯

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

37和誉生物

38康方生物

39宜明昂科

40荣昌生物

41乐普生物

42岸迈生物

43祐和医药

集中于肿瘤免疫检查点抗体2019年逐步申报临床

YH001单克隆抗体，以CTLA-4为靶点， 2019年10月14日美国食品药品管理局（FDA）批准其在研新药YH001的IND申请，进而将在美国进行临床试验。

44嘉和生物

45北海康成

46和誉生物

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

47鸿运华宁

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

48加科思

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

加科思第一个自主研发的原创新药SHP2抑制剂(JAB-3068)已获得多种实体瘤的IIa期临床研究批件并获得美国FDA用于食道癌治疗的孤儿药认定。2019年7月，加科思自主设计开发、具有全球知识产权的小分子口服抗肿瘤药JAB-3312获得美国FDA新药临床试验许可。

49艺妙神州

IM19是靶向CD19的嵌合抗原受体T细胞注射液

IM21是靶向BCMA的嵌合抗原受体T细胞注射液

IM23是潜在靶向CD123的嵌合抗原受体T细胞注射液

50拓臻生物

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

51特瑞斯

52南京圣和

中国创新药收藏了！！！最新最全中国重点肿瘤创新药企业在研管线

附外资中国布局

来源：临床试验大全

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1051182, encodeId=33bb10511823e, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:50:50 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966473, encodeId=02209664e375, content=请问一下药企的研发管线一般怎么获取谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a145475847, createdName=ms5000001075373282, createdTime=Tue May 18 09:34:32 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285883, encodeId=c7d0128588308, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300408, encodeId=45b513004084c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801922, encodeId=e35e8019224c, content=收藏了，感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jul 09 20:59:40 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
2021-09-14 病毒猎手

#收藏#

79 0
[GetPortalCommentsPageByObjectIdResponse(id=1051182, encodeId=33bb10511823e, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:50:50 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966473, encodeId=02209664e375, content=请问一下药企的研发管线一般怎么获取谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a145475847, createdName=ms5000001075373282, createdTime=Tue May 18 09:34:32 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285883, encodeId=c7d0128588308, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300408, encodeId=45b513004084c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801922, encodeId=e35e8019224c, content=收藏了，感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jul 09 20:59:40 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
2021-05-18 ms5000001075373282

请问一下药企的研发管线一般怎么获取谢谢

78 1

展开1条回复
[GetPortalCommentsPageByObjectIdResponse(id=1051182, encodeId=33bb10511823e, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:50:50 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966473, encodeId=02209664e375, content=请问一下药企的研发管线一般怎么获取谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a145475847, createdName=ms5000001075373282, createdTime=Tue May 18 09:34:32 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285883, encodeId=c7d0128588308, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300408, encodeId=45b513004084c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801922, encodeId=e35e8019224c, content=收藏了，感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jul 09 20:59:40 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
2020-07-11 lilianxiang

#创新#

32 0
[GetPortalCommentsPageByObjectIdResponse(id=1051182, encodeId=33bb10511823e, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:50:50 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966473, encodeId=02209664e375, content=请问一下药企的研发管线一般怎么获取谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a145475847, createdName=ms5000001075373282, createdTime=Tue May 18 09:34:32 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285883, encodeId=c7d0128588308, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300408, encodeId=45b513004084c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801922, encodeId=e35e8019224c, content=收藏了，感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jul 09 20:59:40 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
2020-07-11 lqvr

#研发#

39 0
[GetPortalCommentsPageByObjectIdResponse(id=1051182, encodeId=33bb10511823e, content=<a href='/topic/show?id=76565e21782' target=_blank style='color:#2F92EE;'>#收藏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57217, encryptionId=76565e21782, topicName=收藏)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Sep 14 16:50:50 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966473, encodeId=02209664e375, content=请问一下药企的研发管线一般怎么获取谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a145475847, createdName=ms5000001075373282, createdTime=Tue May 18 09:34:32 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285883, encodeId=c7d0128588308, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300408, encodeId=45b513004084c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jul 11 05:07:16 CST 2020, time=2020-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801922, encodeId=e35e8019224c, content=收藏了，感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/02/28/889a1910ded7780f3c049b354f1648b7.jpg, createdBy=2a791737770, createdName=mswert122, createdTime=Thu Jul 09 20:59:40 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
2020-07-09 mswert122

收藏了，感谢分享

135 0

相关资讯

科室
- - 订阅+
  - 更多科室
工具
服务